Publications
Detailed Information
Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ju-Hee | - |
dc.contributor.author | Jeong, Eun-Goo | - |
dc.contributor.author | Choi, Moon-Chang | - |
dc.contributor.author | Kim, Sung-Hak | - |
dc.contributor.author | Song, Sang-Hyun | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Park, Jinah | - |
dc.contributor.author | Park, Jung-Hyun | - |
dc.date.accessioned | 2012-05-25T05:58:04Z | - |
dc.date.available | 2012-05-25T05:58:04Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.citation | MOLECULES AND CELLS; Vol.30 2; 107-112 | ko_KR |
dc.identifier.issn | 1016-8478 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76469 | - |
dc.description.abstract | Histone deacetylase (HDAC) 10, a novel class IIb histone deacetylase, is the most similar to HDAC6, since both contain a unique second catalytic domain. Unlike HDAC6, which is located in the cytoplasm, HDAC10 resides in both the nucleus and cytoplasm. The transcriptional targets of HDAC10 that are associated with HDAC10 gene regulation have not been identified. In the present study, we found that knockdown of HDAC10 significantly increased the mRNA expression levels of thioredoxin-interacting protein (TXNIP) in SNU-620 human gastric cancer cells; whereas inhibition of HDAC1, HDAC2, and HDAC6 did not affect TXNIP expression. TXNIP is the endogenous inhibitor of thioredoxin (TRX), which acts as a cellular antioxidant. Real-time PCR and immunoblot analysis confirmed that inhibition of HDAC10 induced TXNIP expression. Compared to class I only HDAC inhibitors, inhibitors targeting both class I and II upregulated TXNIP, indicating that TXNIP is regulated by class II HDACs such as HDAC10. We further verified that inhibition of HDAC10 induced release of cytochrome c and activated apoptotic signaling molecules through accumulation of reactive oxygen species (ROS). Taken together, our results demonstrate that HDAC10 is involved in transcriptional downregulation of TXNIP, leading to altered ROS signaling in human gastric cancer cells. How TXNIP is preferentially regulated by HDAC10 needs further investigation. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN SOC MOLECULAR & CELLULAR BIOLOGY | ko_KR |
dc.subject | histone deacetylase10 | ko_KR |
dc.subject | human gastric cancer cell | ko_KR |
dc.subject | thioredoxin-interacting protein | ko_KR |
dc.subject | thioredoxin | ko_KR |
dc.subject | reactive oxygen species | ko_KR |
dc.title | Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이주희 | - |
dc.contributor.AlternativeAuthor | 정은구 | - |
dc.contributor.AlternativeAuthor | 최문창 | - |
dc.contributor.AlternativeAuthor | 김성학 | - |
dc.contributor.AlternativeAuthor | 박정현 | - |
dc.contributor.AlternativeAuthor | 송상현 | - |
dc.contributor.AlternativeAuthor | 박진아 | - |
dc.contributor.AlternativeAuthor | 방영주 | - |
dc.contributor.AlternativeAuthor | 김태유 | - |
dc.identifier.doi | 10.1007/s10059-010-0094-z | - |
dc.citation.journaltitle | MOLECULES AND CELLS | - |
dc.description.citedreference | Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933 | - |
dc.description.citedreference | Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x | - |
dc.description.citedreference | Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989 | - |
dc.description.citedreference | Park JH, 2008, BIOCHEM BIOPH RES CO, V368, P318, DOI 10.1016/j.bbrc.2008.01.056 | - |
dc.description.citedreference | Chen J, 2008, DIABETES, V57, P938 | - |
dc.description.citedreference | Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407 | - |
dc.description.citedreference | Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007 | - |
dc.description.citedreference | Lee JH, 2006, MOL CANCER THER, V5, P3085, DOI 10.1158/1535-7163.MCT-06-0419 | - |
dc.description.citedreference | Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256 | - |
dc.description.citedreference | Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670 | - |
dc.description.citedreference | JALOK K, 2005, CANC RES TREAT, V37, P1 | - |
dc.description.citedreference | Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395 | - |
dc.description.citedreference | Nishinaka Y, 2004, CANCER RES, V64, P1287 | - |
dc.description.citedreference | Kawaguchi Y, 2003, CELL, V115, P727 | - |
dc.description.citedreference | de Vos S, 2003, LAB INVEST, V83, P271, DOI 10.1097/01.LAB.0000053913.85892.E9 | - |
dc.description.citedreference | Park JH, 2003, CLIN CANCER RES, V9, P433 | - |
dc.description.citedreference | Ikarashi M, 2002, ANTICANCER RES, V22, P4045 | - |
dc.description.citedreference | Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6 | - |
dc.description.citedreference | Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299 | - |
dc.description.citedreference | Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200 | - |
dc.description.citedreference | Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200 | - |
dc.description.citedreference | Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772 | - |
dc.description.citedreference | Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114 | - |
dc.description.citedreference | Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200 | - |
dc.description.citedreference | Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200 | - |
dc.description.citedreference | Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200 | - |
dc.description.citedreference | Marks PA, 2001, NAT REV CANCER, V1, P194 | - |
dc.description.citedreference | Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572 | - |
dc.description.citedreference | Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080 | - |
dc.description.citedreference | Huang LL, 2000, MOL MED, V6, P849 | - |
dc.description.citedreference | Butler LM, 2000, CANCER RES, V60, P5165 | - |
dc.description.citedreference | Lu JR, 2000, MOL CELL, V6, P233 | - |
dc.description.citedreference | Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056 | - |
dc.description.citedreference | Nishiyama A, 1999, J BIOL CHEM, V274, P21645 | - |
dc.description.citedreference | Buxser SE, 1999, METHOD ENZYMOL, V300, P256 | - |
dc.description.citedreference | Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705 | - |
dc.description.citedreference | KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.